Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications.
Gilpin A, Yang Y. · 2017
Read Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications. by Gilpin A, Yang Y. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5429943.txt.
Introduction
Gilpin and Yang review how to strip cells from tissue while keeping its natural scaffold. Their review appeared in BioMed Research International. Organ donors fall far short of patient need. Over 100,000 people wait for organs in the United States alone. Decellularization offers another path. It washes cells and genetic material out of tissue. What remains is the extracellular matrix. That frame keeps the tissue's shape and chemical cues.
New cells can then be seeded onto the frame. The hope is a working tissue or organ. Methods fall into three groups. Chemical and enzyme treatments dissolve cell parts. Physical methods use force, cold, or pressure. Many protocols mix the two. Each route trades cell removal against matrix damage. The review compares those trade-offs by tissue type. It also shows uses for cell sheets, tissues, and whole organs. The field aims at transplants without donor shortage.
Catalog record
| CREATOR | Gilpin A, Yang Y. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Decellularization Strategies for Regenerative Medicine: From Processing Techniques to Applications By Anna Gilpin, Yong Yang Published in: BioMed Research International DOI: 10.1155/2017/9831534 ABSTRACT As the gap between donors and patients in need of an organ transplant continues to widen, research in regenerative medicine seeks to provide alternative strategies for treatment. One of the most promising techniques for tissue and organ regeneration is decellularization, in which the extracellular matrix (ECM) is isolated from its native cells and genetic material in order to produce a natural scaffold. The ECM, which ideally retains its inherent structural, biochemical, and biomechanical cues, can then be recellularized to produce a functional tissue or organ. While decellularization can be accomplished using chemical and enzymatic, physical, or combinative methods, each strategy has both benefits and drawbacks. The focus of this review is to compare the advantages and disadvantages of these methods in terms of their ability to retain desired ECM characteristics for particular tissues and organs. Additionally, a few applications of constructs engineered using decellularized cell sheets, tissues, and whole organs are discussed. 1. INTRODUCTION Tissue and organ failure is currently one of the biggest health issues our society faces. Arising from disease or trauma, complete treatment typically requires the reparation or replacement of the affected organ. Conventional practices utilize organs from either live or deceased donors for the procedure of transplantation. However, the deficit between donors and patients requiring a new organ has grown substantially in recent years, so much that there are more than 100,000 patients on waiting lists for organs in the United States alone [1]. This epidemic has led researchers to explore alternative methods of treatment, in particular tissue engineering, which seeks to reduce organ specificity and thus alleviate the necessity for organ donation. Tissue engineering aims at replacing or regenerating human tissues or organs in order to restore or establish normal function [2]. The tissue engineering triad consists of three main factors, the cells, signaling molecules, and scaffold, which support and rely upon one another. Specifically, the scaffold, together with integrated signaling molecules, provides structural, biochemical, and biomechanical cues to guide and regulate cell behavior and tissue development. Scaffolds can be prepared through a variety of methods and materials, both synthetic and natural. Synthetic scaffolds are beneficial in that their structure and mechanical properties can be manipulated and controlled with the goal of producing an optimal environment for a particular cell type or cell set. Among these properties, matrix stiffness and topography show profound influences on cell growth and differentiation. Stiffer polymers like poly(lactic-co-glycolic acid) (PLGA) have been used in cartilage and bone tissue engineering [3, 4], while softer hydrogels, benefitting from their tunable mechanical properties and adjustable composition, have been used for soft tissues [5]. Interestingly, differentiation towards a desirable lineage can be facilitated on a matrix having stiffness similar to that of the natural tissue [6, 7]. The nanotopography of the scaffold also plays an important role in cell regulation. In addition to inducing pronounced changes to cell morphology and gene expression [8–11], nanotopography can regulate the differentiation of stem cells into certain lineages such as neuron [8, 12, 13], muscle [14], and bone [15, 16]. Thus, cell behavior can be regulated through tailoring the scaffold's properties. Technologies like electrospinning and 3D printing enable the control of these properties through optimization in the materials and processing parameters. Electrospun constructs, which consist of arranged polymeric nanofibers, have been utilized in engineering several tissue structures, including vascular grafts [17], bone [18], and myocardium [19]. Furthermore, 3D printing in scaffold design allows for the integration of features like vasculature [20, 21] and the control of scaffold architecture [22], using synthetic polymers or bioinks. These methods show great promise in their ability to control key properties of scaffolds and to subsequently manipulate cell behavior for tissue engineering. Because many challenges are associated with preparing synthetic scaffolds that recapitulate the complexity of the cell microenvironment, there has been increasing interest in utilizing naturally derived extracellular matrix (ECM) itself. This biologic scaffold is obtained through the process of decellularization. The ultimate goal of decellularization is to rid the ECM of native cells and genetic materials such as DNA while maintaining its structural, biochemical, and biomechanical cues. The decellularized ECM can then be repopulated with a patient's own cells to produce a personalized tissue. Decellularized ECM has been successfully used to recreate various types of tissues and organs including blood vessel [23–25], heart valve [26, 27], cornea [28–30], trachea [31], esophagus [32], urinary bladder [33], kidney [34, 35], liver [36–39], lung [40, 41], and heart [42, 43]. Figure 1 outlines the overall process of developing engineered tissues or organs from decellularization to recellularization. In the decellularization process, chemical and enzymatic, physical, or combinative methods are utilized to remove cells and DNA from the tissue while preserving its structural and regulatory proteins. To assess the quality of decellularized ECM, four aspects of the ECM are measured: removal of cells, elimination of genetic material, preservation of protein content, and retention of mechanical properties. Cell and genetic material removal is critical in preventing immunorejection of the construct to seeded cells. The criteria for assessing the efficacy of removal of these components is suggested as follows: the decellularized ECM must have (1) less than 50 ng double-stranded DNA (dsDNA) per mg ECM dry weight, (2) less than 200 bp DNA fragment length, and (3) no visible nuclear material by 4′,6-diamidino-2-phenylindole (DAPI) staining [44]. Additionally, protein content remaining in the ECM should be evaluated, with emphasis on the structural proteins like collagen, fibronectin, and laminin; glycosaminoglycans (GAGs); and growth factors. Moreover, the mechanical properties including elastic modulus and tensile strength, depending on the application, should match the original tissue. In this review, decellularization strategies are evaluated based upon their efficacy in these four areas, in addition to the toxicity and overall efficiency of the technique, followed by a few applications of decellularized ECM. 2. DECELLULARIZATION STRATEGIES Decellularization has been performed through chemical, physical, or combinative methods. An evaluation of these strategies will first focus on the removal of cells and genetic material followed by the maintenance of structural proteins. In addition, mechanical properties and ultrastructure of the tissue or organ before and after treatment will be compared. Emphasis will be placed upon the method's ability to retain the characteristics necessary for successful recreation of the tissue or organ. Table 1 summarizes the chemical and enzymatic agents and mechanical techniques used for decellularization. 2.1. Chemical and Enzymatic Approaches Several types of chemicals have been used in decellularization, including surfactants, acids, and bases. Surfactants, the most common decellularizing agents, typically work by lysing cells through disarranging the phospholipid cell membrane [57]. These agents are classified based upon their charge, as they are ionic, nonionic, or zwitterionic. Acids like peracetic acid and bases like sodium hydroxide solubilize the cell membrane and nuclear material by utilizing their intrinsically charged properties. 2.1.1. Surfactants The widely used ionic surfactant, sodium dodecyl sulfate (SDS), has been successful in a number of applications in decellularization because of its ability to efficiently remove cells and genetic material. For example, it was the major agent used in the whole rat heart perfusion decellularization [42]. SDS treatments have met the standard requirements of complete